Biofrontera Files sNDA to Broaden Ameluz PDT Label for Actinic Keratoses
Biofrontera has submitted an sNDA to the FDA seeking approval of Ameluz PDT for actinic keratoses on body areas beyond its currently labeled treatment sites.
Topic
Ameluz
Topic
Ameluz
FDA Approval of Ameluz Expands Skin Cancer Treatment Options
The FDA has approved Ameluz, a decision specialists hail as a meaningful addition to the skin cancer treatment armamentarium, Med…